サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1417455

脊椎生物学的製剤市場レポート：2030年までの動向、予測、競合分析

Spine Biologic Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 - page report | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

脊椎生物学的製剤市場レポート：2030年までの動向、予測、競合分析
出版日: 2024年01月29日
発行: Lucintel
ページ情報: 英文 150 - page report
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

脊椎生物学的製剤の動向と予測

脊椎生物学的製剤の世界市場は、2024年から2030年までのCAGRが4.5%で、2030年までに推定33億米ドルに達すると予想されます。この市場の主な促進要因は、脊椎変形の罹患率の上昇と、侵襲性の低い医療技術に対する認識と患者の志向の高まりです。世界の脊椎生物学的製剤市場の将来は、病院と外来手術センター市場における機会によって有望視されています。

脊椎生物学的製剤市場の洞察

Lucintelは、骨移植は病気感染の可能性を低くするため、予測期間中も最大セグメントであり続けると予測しています。

この市場の中では、病院が最も高い成長を遂げると予想されます。これは、病院が広範なヘルスケア資源を備えており、専門部門や学際的チームを包含しており、脊椎ケアサービスの完全なスペクトルを提供できるためです。

北米は、強固なヘルスケアシステム、主要な業界リーダーの存在、この地域における低侵襲処置に対する認識と要望の高まりにより、予測期間中に最も高い成長が見込まれます。

よくある質問

Q1.市場規模は？

A1.世界の脊椎生物学的製剤市場は、2030年までに推定33億米ドルに達すると予想されています。

Q2.市場の成長予測は？

A2.脊椎生物学的製剤の世界市場は、2024年から2030年にかけてCAGR 4.5%で成長する見込みです。

Q3.市場の成長に影響を与える主な促進要因は？

A3.この市場の主な促進要因は、脊椎変形の罹患率の上昇と、侵襲性の低い医療技術に対する認識と患者の志向の高まりです。

Q4.市場の主要セグメントは？

A4.脊椎生物学的製剤市場の将来は、病院と外来手術センター市場に機会があり、有望です。

Q5.市場の主要企業は？

A5.脊椎生物学的製剤の主要企業は以下の通り。

  • Zimmer Biomet Holdings
  • Johnson and Johnson
  • Orthofix Medical
  • Stryker
  • Arthrex
  • Medtronic
  • K2M
  • Exactech
  • Wright Medical Technology
  • Nuvasive

Q6.今後、最大となる市場セグメントは？

A6.Lucintelは、骨移植は病気感染の可能性を低くするため、予測期間中最大のセグメントであり続けると予測しています。

Q7.市場において、今後5年間に最大になると予想される地域は？

A7.北米は、強固なヘルスケアシステム、主要な業界リーダーの存在、この地域における低侵襲処置への認識と欲求の高まりにより、予測期間中に最も高い成長を示すと予想されます。

Q8.レポートのカスタマイズは可能？

A8.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の脊椎生物学的製剤市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年～2030年の市場動向と予測分析

  • マクロ経済動向（2018年～2023年）と予測（2024年～2030年）
  • 世界の脊椎生物製剤市場動向（2018年～2023年）と予測（2024年～2030年）
  • 世界の脊椎生物学的製剤市場、製品別
    • 骨移植片
    • 骨移植片代替品
    • 多血小板血漿
    • 骨髄吸引療法
    • その他
  • 世界の脊椎生物学的製剤市場、材料別
    • 前頚椎椎間板切除術と固定術
    • 後部腰椎椎体間固定術
    • 経椎間孔腰椎椎体間固定術
    • 前部腰椎椎体間固定術
    • 側方腰椎体間固定術
  • 世界の脊椎生物製剤市場、最終用途産業別
    • 病院
    • 外来外科
    • その他

第4章 2018年～2030年の地域別の市場動向と予測分析

  • 地域別の世界の脊椎生物製剤市場
  • 北米の脊椎生物製剤市場
  • 欧州の脊椎生物製剤市場
  • アジア太平洋の脊椎生物製剤市場
  • その他地域の脊椎生物製剤市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 製品別の世界の脊椎生物学的製剤市場の成長機会
    • 材料別の世界の脊椎生物学的製剤市場の成長機会
    • 最終用途産業別の世界の脊椎生物製剤市場の成長機会
    • 地域別の世界の脊椎生物学的製剤市場の成長機会
  • 世界の脊椎生物学的製剤市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の脊椎生物製剤市場の能力拡大
    • 世界の脊椎生物学的製剤市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Zimmer Biomet Holdings
  • Johnson and Johnson
  • Orthofix Medical
  • Stryker
  • Arthrex
  • Medtronic
  • K2M
  • Exactech
  • Wright Medical Technology
  • Nuvasive
目次

Spine Biologic Trends and Forecast

The future of the global spine biologic market looks promising with opportunities in the hospitals and ambulatory surgical centres markets. The global spine biologic market is expected to reach an estimated $3.3 billion by 2030 with a CAGR of 4.5% from 2024 to 2030. The major drivers for this market are rising incidence of spinal deformities and growing recognition and patient inclination toward less invasive medical techniques.

A more than 150-page report is developed to help in your business decisions.

Spine Biologic by Segment

The study includes a forecast for the global spine biologic by product, material, end use industry, and region.

Spine Biologic Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Bone Grafts
  • Bone Graft Substitutes
  • Platelet-Rich Plasma
  • Bone Marrow Aspirate Therapy
  • Others

Spine Biologic Market by Material [Shipment Analysis by Value from 2018 to 2030]:

  • Anterior Cervical Discectomy & Fusion
  • Posterior Lumbar Interbody Fusion
  • Transforaminal Lumbar Interbody Fusion
  • Anterior Lumbar Interbody Fusion
  • Lateral Lumbar Interbody Fusion

Spine Biologic Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital
  • Ambulatory Surgical
  • Others

Spine Biologic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Spine Biologic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies spine biologic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the spine biologic companies profiled in this report include-

  • Zimmer Biomet Holdings
  • Johnson and Johnson
  • Orthofix Medical
  • Stryker
  • Arthrex
  • Medtronic
  • K2M
  • Exactech
  • Wright Medical Technology
  • Nuvasive

Spine Biologic Market Insights

Lucintel forecasts that bone graft will remain the largest segment over the forecast period due to it lowers the chances of disease transmission.

Within this market, hospital is expected to witness the highest growth due to they are furnished with extensive healthcare resources, encompassing specialized divisions and interdisciplinary teams capable of delivering a complete spectrum of spinal care services.

North America is expected to witness highest growth over the forecast period due to robust healthcare system, the presence of key industry leaders, and a growing awareness and desire for minimally invasive procedures in this region.

Features of the Global Spine Biologic Market

Market Size Estimates: Spine biologic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Spine biologic market size by product, material, end use industry, and region in terms of value ($B).

Regional Analysis: Spine biologic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, material, end use industry, and regions for the spine biologic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the spine biologic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the spine biologic market size?

Answer: The global spine biologic market is expected to reach an estimated $3.3 billion by 2030.

Q2. What is the growth forecast for spine biologic market?

Answer: The global spine biologic market is expected to grow with a CAGR of 4.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the spine biologic market?

Answer: The major drivers for this market are rising incidence of spinal deformities and growing recognition and patient inclination toward less invasive medical techniques.

Q4. What are the major segments for spine biologic market?

Answer: The future of the spine biologic market looks promising with opportunities in the hospitals and ambulatory surgical centres markets.

Q5. Who are the key spine biologic market companies?

Answer: Some of the key spine biologic companies are as follows.

  • Zimmer Biomet Holdings
  • Johnson and Johnson
  • Orthofix Medical
  • Stryker
  • Arthrex
  • Medtronic
  • K2M
  • Exactech
  • Wright Medical Technology
  • Nuvasive

Q6. Which spine biologic market segment will be the largest in future?

Answer: Lucintel forecasts that bone graft will remain the largest segment over the forecast period due to it lowers the chances of disease transmission.

Q7. In spine biologic market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to robust healthcare system, the presence of key industry leaders, and a growing awareness and desire for minimally invasive procedures in this region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the spine biologic market by product (bone grafts, bone graft substitutes, platelet-rich plasma, bone marrow aspirate therapy, and others), material (anterior cervical discectomy & fusion, posterior lumbar interbody fusion, transforaminal lumbar interbody fusion, anterior lumbar interbody fusion, and lateral lumbar interbody fusion), end use industry (hospital, ambulatory surgical, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Spine Biologic Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Spine Biologic Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Spine Biologic Market by Product
    • 3.3.1: Bone Grafts
    • 3.3.2: Bone Graft Substitutes
    • 3.3.3: Platelet-Rich Plasma
    • 3.3.4: Bone Marrow Aspirate Therapy
    • 3.3.5: Others
  • 3.4: Global Spine Biologic Market by Material
    • 3.4.1: Anterior Cervical Discectomy & Fusion
    • 3.4.2: Posterior Lumbar Interbody Fusion
    • 3.4.3: Transforaminal Lumbar Interbody Fusion
    • 3.4.4: Anterior Lumbar Interbody Fusion
    • 3.4.5: Lateral Lumbar Interbody Fusion
  • 3.5: Global Spine Biologic Market by End Use Industry
    • 3.5.1: Hospital
    • 3.5.2: Ambulatory Surgical
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Spine Biologic Market by Region
  • 4.2: North American Spine Biologic Market
    • 4.2.2: North American Spine Biologic Market by End Use Industry: Hospital, Ambulatory Surgical, and Others
  • 4.3: European Spine Biologic Market
    • 4.3.1: European Spine Biologic Market by Product: Bone Grafts, Bone Graft Substitutes, Platelet-Rich Plasma, Bone Marrow Aspirate Therapy, and Others
    • 4.3.2: European Spine Biologic Market by End Use Industry: Hospital, Ambulatory Surgical, and Others
  • 4.4: APAC Spine Biologic Market
    • 4.4.1: APAC Spine Biologic Market by Product: Bone Grafts, Bone Graft Substitutes, Platelet-Rich Plasma, Bone Marrow Aspirate Therapy, and Others
    • 4.4.2: APAC Spine Biologic Market by End Use Industry: Hospital, Ambulatory Surgical, and Others
  • 4.5: ROW Spine Biologic Market
    • 4.5.1: ROW Spine Biologic Market by Product: Bone Grafts, Bone Graft Substitutes, Platelet-Rich Plasma, Bone Marrow Aspirate Therapy, and Others
    • 4.5.2: ROW Spine Biologic Market by End Use Industry: Hospital, Ambulatory Surgical, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Spine Biologic Market by Product
    • 6.1.2: Growth Opportunities for the Global Spine Biologic Market by Material
    • 6.1.3: Growth Opportunities for the Global Spine Biologic Market by End Use Industry
    • 6.1.4: Growth Opportunities for the Global Spine Biologic Market by Region
  • 6.2: Emerging Trends in the Global Spine Biologic Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Spine Biologic Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Spine Biologic Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Zimmer Biomet Holdings
  • 7.2: Johnson and Johnson
  • 7.3: Orthofix Medical
  • 7.4: Stryker
  • 7.5: Arthrex
  • 7.6: Medtronic
  • 7.7: K2M
  • 7.8: Exactech
  • 7.9: Wright Medical Technology
  • 7.10: Nuvasive